Molecular and immunomodulatory actions of new antiasthmatic agents: exploring the diversity of biologics in Th2 endotype asthma

Asthma is a major respiratory disorder characterised by chronic inflammation and airway remodelling. It affects about 1–8% of the global population and is responsible for over 461,000 deaths annually. Until recently, the pharmacotherapy of severe asthma involved high doses of inhaled corticosteroids...

Full description

Bibliographic Details
Main Authors: Okwuofu, Emmanuel Oshiogwe, Chee, Audrey Hui Yong, Chee, Jonathan Woei Lim, Stanslas, Johnson
Format: Article
Published: Academic Press 2022